Mittal R, Kowal C, Starzl T, Van Thiel D, Bron K, Iwatsuki S, Schade R, Straub W, Dekker A
J Clin Oncol. 1984 Jun;2(6):637-42. doi: 10.1200/JCO.1984.2.6.637.
Computerized tomography (CT) of liver is used in oncologic practice for staging tumors, evaluating response to treatment, and screening patients for hepatic resection. Because of the impact of CT liver scan on major treatment decisions, it is important to assess its accuracy. Patients undergoing liver transplantation or resection provide a unique opportunity to test the accuracy of hepatic-imaging techniques by comparison of findings of preoperative CT scan with those at gross pathologic examination of resected specimens. Forty-one patients who had partial hepatic resection (34 patients) or liver transplantation (eight patients) for malignant (30 patients) or benign (11 patients) tumors were evaluable. Eight (47%) of 17 patients with primary malignant liver tumors, four (31%) of 13 patients with metastatic liver tumors, and two (20%) of 10 patients with benign liver tumors had tumor nodules in resected specimens that were not apparent on preoperative CT studies. These nodules varied in size from 0.1 to 1.6 cm. While 11 of 14 of these nodules were less than 1.0 cm, three of 14 were greater than 1.0 cm. These results suggest that conventional CT alone may be insufficient to accurately determine the presence or absence of liver metastases, extent of liver involvement, or response of hepatic metastases to treatment.
肝脏计算机断层扫描(CT)在肿瘤学实践中用于肿瘤分期、评估治疗反应以及筛选适合肝切除的患者。由于肝脏CT扫描对主要治疗决策有影响,评估其准确性很重要。接受肝移植或肝切除的患者提供了一个独特的机会,通过将术前CT扫描结果与切除标本的大体病理检查结果进行比较,来检验肝脏成像技术的准确性。41例因恶性肿瘤(30例)或良性肿瘤(11例)接受部分肝切除(34例)或肝移植(8例)的患者可进行评估。17例原发性恶性肝肿瘤患者中有8例(47%)、13例转移性肝肿瘤患者中有4例(31%)、10例良性肝肿瘤患者中有2例(20%)在切除标本中有术前CT检查未发现的肿瘤结节。这些结节大小从0.1厘米到1.6厘米不等。其中14个结节中有11个小于1.0厘米,14个中有3个大于1.0厘米。这些结果表明,仅常规CT可能不足以准确确定肝转移的有无、肝脏受累程度或肝转移对治疗的反应。